Introduction
============

Reoperation after breast-conserving surgery (BCS) for breast cancer (BC) could be proposed for positive or close margins. Guidelines for reoperation have evolved during the past years: for invasive BC, margins ≥5 mm and then 2 mm and "no ink on tumor" are required, and for ductal carcinoma in situ (DCIS), margins ≥2 mm are usually required.

Reoperation type, re-excision or mastectomy, depends on several factors in relation to patient's and pathological tumor characteristics, mainly 1) patient's choice informed of third reoperation risk and no postmastectomy radiotherapy (PMRT) for patients without axillary lymph node macrome-tastases; 2) breast size, tumor size, and tumor localization; and 3) possibility of surgical resection (ie, oncoplasty).

Several studies have reported reoperation rate and type of reoperation after BCS,[@b1-cmar-11-2507]--[@b15-cmar-11-2507] but only a few focused on predictive factors determining reoperation type.[@b11-cmar-11-2507],[@b13-cmar-11-2507],[@b16-cmar-11-2507] We have analyzed institutional BC database in order to determine rates and associated factors for reoperation, mastectomy, and third reoperation.

Patients and methods
====================

All patients undergoing BCS in our institution, between January 1995 and December 2017, were included, except those with cT4 and inflammatory BC. A process is in place for institutional BC database to ensure data integrity, accuracy, and completeness. Patient's and clinical characteristics (cTN stage, age, breast tumor localization), pathologic results (tumor size, Scarff--Bloom--Richardson \[SBR\] grade, lymphovascular invasion, histological type, tumor focality, phenotype, in situ component, focal \[\<3 fields at magnification 40\], or diffuse positive margins), and treatment (adjuvant chemotherapy \[AC\] or neoadjuvant chemotherapy \[NAC\]) were analyzed. Three periods were determined: P1 (1995--2004) with ≥5 mm margins required, P2 (2005--2010) with ≥2 mm margins required, and P3 (after 2010) with negative margins with no ink on tumor.

Reoperation rate and type of reoperation rates (re-excision or mastectomy) and second reoperation after re-excision were analyzed. Factors associated with reoperation, mastectomy, and third intervention were determined. We analyzed interval times between first surgery and reoperation for DCIS, for invasive BC with distinction between patients with or without AC. Overall survival and disease-free survival were compared between patients with and without reoperation.

BCS was undertaken with systematic resection from the subcutaneous layer to major pectoralis muscle and cutaneous resection when tumor was near the skin or when cutaneous retraction was observed. The specimen was pinned on a plate, oriented, and lateral margins inked.

We performed literature review in order to discuss these results.

Statistics
----------

Univariate comparisons were performed using chi-square test. To assess the independent prognostic effect of the variables, a multivariable analysis, using binary logistic regression, was performed. The multivariable model was fitted for those factors that were statistically significant in the univariate analyses. ORs and 95% CIs were estimated for each variable compared to the reference group. Survivals results were compared using the log-rank test. A two-sided *P*-value of \<0.05 was considered as statistically significant. Data analysis was performed using SPSS version 16.0 (SPSS Inc., Chicago, IL, USA).

Results
=======

Patients
--------

A total of 10,761 patients were included in the analysis: 1,161 DCIS and 9,600 invasive BC. The characteristics of patients are reported in [Table 1](#t1-cmar-11-2507){ref-type="table"}.

Reoperation
-----------

Reoperation rate was 29.4% (3,168/10,761: 95% CI 28.5--30.3): 41.4% (481/1,161) and 28.0% (2,687/9,600) for DCIS and invasive BC, respectively. For the total cohort, all factors analyzed were significantly different for reoperation rate in the univariate analysis ([Table 1](#t1-cmar-11-2507){ref-type="table"}). In the multivariate analysis for DCIS, tumor size ≥20 mm increased reoperation rate and age \>50 years, P2--3 periods, and tumor localization (upper superior quadrant and external superior and inferior quadrants) decreased reoperation rates ([Table 2](#t2-cmar-11-2507){ref-type="table"}). In multivariate analysis for invasive BC, lobular tumor, bifocal or multifocal tumors, presence of lymphovascular peritumoral invasion (LVI), DCIS component, and Her2-positive tumors increased reoperation rates and age \>40 years, triple-negative tumors, NAC, and noncentral tumors decreased reoperation rates ([Table 3](#t3-cmar-11-2507){ref-type="table"}).

Reoperation type
----------------

For patients, who needed reoperation, a mastectomy was performed at first reoperation in 51.9% (1,645/3,168; 241/481: 50.1% for DCIS and 1,404/2,687: 52.2% for invasive BC) and mastectomy was required after first reoperation with re-excision in 13.46% (205/1,523: 35 for DCIS and 170 for invasive BC) with a total mastectomy rate of 58.4% (1,850/3,168; 276/481: 57.4% for DCIS and 1,574/2,687: 58.6% for invasive BC). For DCIS, the mastectomy rate was higher for grade 2 tumors and tumor sizes ≥20 mm ([Table 4](#t4-cmar-11-2507){ref-type="table"}). For invasive BC, the mastectomy rate was higher for lobular tumors, bifocal or multifocal tumors, tumor sizes ≥20 mm, Her2-positive tumors, and diffuse positive margins and lower for age \>50 years and patients treated during the last period ([Table 5](#t5-cmar-11-2507){ref-type="table"}).

Among patients with re-excision, factors associated with reoperation with mastectomy in binary logistic regression were tumor size ≥20 mm; multifocal tumors, which increased mastectomy rates; and age \>50 years, which decreased mastectomy rates ([Table 6](#t6-cmar-11-2507){ref-type="table"}).

Interval time
-------------

The median interval time between first surgery and reoperation for DCIS was 35 days (mean: 44.58, 95% CI 41.3--47.8) and 78 days for patients with a second reoperation (mean 90.9, 95% CI 75.9--105.8). Median interval time between first operation and radiotherapy for patients with DCIS was 55 days (mean 63, 95% CI 60.4--65.6) and for patients with re-excision (n = 238) or no reoperation (n = 562), it was 77 days (mean 89.8, 95% CI 83.4--96.1) or 47 days (mean 51.7, 95% CI 49.8--53.6), respectively.

The median interval time between first surgery and reoperation (first reoperation) for invasive BC was 29 days (mean 47.7, 95% CI 39.6--55.8) and 123 days for patients with a second reoperation (mean: 133, 95% CI 121--145). When AC was administered, reoperation was performed before or after chemotherapy. The median interval time between first surgery and reoperation for invasive BC was 28 days (mean 33, 95% CI 31.8--34.1) for patients without any treatment before reoperation (AC after reoperation or patients with previous NAC or patients without AC before reoperation) and 173.5 days (mean 179, 95% CI 174--184) for patients with AC before reoperation.

The median time interval between first operation and radiotherapy for patients with invasive BC without AC was 73 days (mean 142 days, 95% CI 14--270) and 46 days for patients with or without reoperation (mean 47.3 days, 95% CI 46--48), respectively.

For patients with invasive BC and AC, the median interval time between first operation and AC was 42 days (mean 47.3 days, 95% CI 45.8--48.9) and 34 days (mean 36.9 days, 95% CI 36--38) for patients with reoperation and without reoperation, respectively, and the median interval time between first operation and radiotherapy was 188 days (mean 186.5 days, 95% CI 184--189) and 167 days (mean 158 days, 95% CI 156--160) for patients with reoperation and without reoperation, respectively.

Survival
--------

The median follow-up was 53.2 months (95% CI 56.7--89.0 months). Overall survival and disease-free survival were not different between patients with and without reoperation (log-rank test: 0.393 and 0.963 for invasive BC and 0.212 and 0.231 for DCIS).

Discussion
==========

In our study, the reoperation rate for DCIS was high (41.4%) but lower during the two last periods (decrease of 24.6%), and higher mastectomy rates (49.9%) were reported for tumors ≥20 and \<50 mm. These results are concordant with literature results.[@b17-cmar-11-2507] Higher reoperation rates were also observed in the literature survey results for lobular carcinomas. The reoperation rate for invasive BC was 28.0%, higher for young patients, triple-negative and Her2-positive tumors, lobular carcinomas, and multifocal tumors and lesser after NAC. Higher mastectomy rates for reoperation were also observed in our study mainly for these same factors. However, NAC was proposed for patients who need mastectomy before NAC or for patients with aggressive tumors (ie, SBR grade 3, Her2-positive, triple negative) and axillary involvement at ultrasonography and percutaneous biopsy.

In literature review, the mean reoperation rate (re-excision or mastectomy) was 27.49% (95% CI 27.4--27.6, range: 10.2%--34%) among 402,357 patients with BC (DCIS or invasive) operation.[@b1-cmar-11-2507]--[@b15-cmar-11-2507]

Re-excision rates for BCS are extremely variable across the literature. This is mainly due to no clear consensus regarding the definition of a negative margin, different preoperative and intraoperative tumor localizing methods, differences in intraoperative imaging techniques, specimen inking by surgeons or pathologists, the use of shave margins, tumor vs lumpectomy size, oncoplastic resections, volume of breast surgery per year by surgeons, and surgeon threshold to offer re-excision vs mastectomy for positive margins.[@b13-cmar-11-2507],[@b18-cmar-11-2507],[@b19-cmar-11-2507]

When analysis of reoperation rates was performed according to three periods of treatment, we observed a decrease in reoperation rates among successive periods from 28.96% (4,594/15,861, 95% CI 28.3--29.7) to 30.66% (79,708/259,943, 95% CI 30.5--30.8) and 21.34% (20,016/93,779, 95% CI 21.1--21.6).[@b1-cmar-11-2507],[@b3-cmar-11-2507]--[@b7-cmar-11-2507],[@b9-cmar-11-2507]--[@b15-cmar-11-2507] In the study reported by Morrow et al,[@b9-cmar-11-2507] surgery after initial lumpectomy declined by 16% (*P* \< 0.001) from 2013 to 2015.

Reoperation rates were different for invasive BC and DCIS in literature reviews: 26.56% (86,797/326,828, 95% CI 26.4--26.7, range: 10.4--30.5) and 33.1% (21,594/65,261, 95% CI 32.7--33.5, range: 8.97--41.4),[@b1-cmar-11-2507]--[@b3-cmar-11-2507],[@b7-cmar-11-2507],[@b14-cmar-11-2507] respectively. However, reoperation rates differed between histological types of invasive BC: 26.98% for ductal invasive BC, 40.6% for lobular invasive BC, and 21.83% for others invasive histological types.[@b2-cmar-11-2507]

For DCIS, there was no statistically significant difference in locoregional recurrence (LRR) for patients with margins \<2 versus ≥2 mm who received radiotherapy (10-year LRR 4.8% vs 3.3%, respectively; *P* = 0.72).[@b20-cmar-11-2507] One other large study evaluating the relationship between margin width and recurrence did not identify a significant association of recurrence with margin width of ≤2 mm compared with larger margins for patients receiving radiotherapy.[@b21-cmar-11-2507] However, Morrow et al[@b22-cmar-11-2507] reported in 2016 that 2 mm margin minimizes the risk of ipsilateral breast tumor recurrence (IBTR) compared with smaller negative margins, using a meta-analysis of margin width and IBTR from a systematic review.

A conservative reoperation was done is \~50% of patients with DCIS or ductal invasive BC and lesser for lobular invasive BC (\~30%) with a decrease in mastectomy rates among successive periods analyzed. In our study, interval times between first surgery and adjuvant treatments increased for patients who needed reoperation but without significant impact on survival.

A third intervention for mastectomy had been reported in three studies,[@b1-cmar-11-2507],[@b3-cmar-11-2507],[@b6-cmar-11-2507] and in our study: mastectomy rate after re-excision was 13.54% (1,059/7,818, 95% CI 12.8--14.3). Mastectomy rates among 108,446 patients with reoperation in the literature review were 40.77% (95% CI 40.5--41.1, range: 10.7--62.1) and 55.4% (95% CI 54.6--56.2) for studies with analysis of a third intervention for mastectomy (8,309/14,998).[@b1-cmar-11-2507],[@b3-cmar-11-2507],[@b6-cmar-11-2507]

When analysis of mastectomy rates was performed according to the three periods of treatment (DCIS and invasive), we observed a decrease in mastectomy rates among successive periods from 59.62% (2,739/4,594, 95% CI 58.2--61.0) to 48.8% (2,532/5,191, 95% CI 47.4--50.2) and 36.81% (6,892/17,903, 95% CI 36.1--37.5).[@b3-cmar-11-2507],[@b4-cmar-11-2507],[@b6-cmar-11-2507],[@b7-cmar-11-2507],[@b9-cmar-11-2507],[@b11-cmar-11-2507] In the study reported by Wilke et al,[@b5-cmar-11-2507] the mastectomy rate was 37.9% for patients operated between 2004 and 2010.

Mastectomy rates were different according to histological types of tumor: 49.7% (1,960/3,942, 95% CI 48.1--51.3) for DCIS,[@b1-cmar-11-2507],[@b4-cmar-11-2507]--[@b6-cmar-11-2507],[@b8-cmar-11-2507],[@b11-cmar-11-2507],[@b13-cmar-11-2507],[@b14-cmar-11-2507] 50.9% (9,446/18,566, 95% CI 50.2--51.6) for invasive BC, 55.7% (95% CI 54.5--56.9) for ductal invasive BC, 70.5% (95% CI 68.3--72.7) for lobular invasive BC, and 60.9% (95% CI 57.8--64.0) for other invasive histological types.[@b2-cmar-11-2507]

After initial oncoplastic surgery, close or positive margins was reported in 12.3% (342/2,772, 95% CI 11.1--13.5) of patients in a meta-analysis reported in 2014,[@b23-cmar-11-2507] and the mastectomy rate for reoperation after initial oncoplastic resection was high: 64% in Clough et al's[@b24-cmar-11-2507] study and 61.3% in Losken et al[@b23-cmar-11-2507] meta-analysis.

Interval time between surgery or first surgery for patients who need reoperation and adjuvant treatment: even if interval time was higher for patients with reoperation, we did not observe impact on survival results between patients with or without reoperation.

Conclusion
==========

A decrease of reoperation rate and mastectomy rate in future years is probably in relation with negative margin resection without several mm of margin, more accurate preoperative radiologic analysis, particularly for lobular and multifocal tumors; more oncoplastic resections; and more NAC. A third intervention with mastectomy was required in about 13%--14% of patients. Information about risk of a third intervention should be given to patients who require reoperation.

Even if interval time between surgery and adjuvant treatments was higher for patients with reoperation, survival results were not different between patients with and without reoperation.
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###### 

Reoperation rates for all patients and for DCIS or invasive BC

  10,761 patients                          Total   Reoperation   *χ*2   DCIS       Reoperation   *χ*2   Invasive   Reoperation   *χ*2       Mastectomy   *χ*2               
  --------------------------- ------------ ------- ------------- ------ ---------- ------------- ------ ---------- ------------- ---------- ------------ ------- ---------- ----------
                                                                                                                                                                            
  Age, years                  ≤40          867     348           40.1   \<0.0001   79            54.4   \<0.0001   788           38.7       \<0.0001     192     63.0       \<0.0001
  41--50                      2,364        851     36.0                 259        51.4                 2,105      34.1                     428          59.6               
  51--74                      6,563        1,799   27.4                 770        37.4                 5,793      26.1                     709          46.9               
  ≥75                         967          170     17.6                 53         32.1                 914        16.7                     75           49.0               
                                                                                                                                                                            
  DCIS -- IT and peripheric   No (\<25%)   7,456   1,859         24.9   \<0.0001                                   6,308         22.0       \<0.0001     678     48.9       \<0.0001
  Yes (≥25%)                  3,306        1,309   39.6                                                 3,292      39.5                     726          55.8               
                                                                                                                                                                            
  Focality                    Unifocal     9,456   2,578         27.3   \<0.0001   945           43.5   0.002      8,511         25.5       \<0.0001     1,017   46.9       \<0.0001
  Bifocal                     607          308     50.7                 55         45.5                 552        51.3                     185          65.4               
  Multifocal                  251          164     65.3                 17         76.5                 234        64.5                     131          86.8               
  Unknown                     269          110     40.9                 96         30.2                 173        46.8                     68           84.0               
                                                                                                                                                                            
  Chemotherapy                No           5,751   1,357         23.6   \<0.0001                                   4,623         19.3       \<0.0001     363     40.8       \<0.0001
  Adjuvant                    4,453        1,711   38.4                                                 4,432      38.3                     983          57.9               
  Neo-adjuvant                525          91      17.3                                                 514        17.3                     55           61.8               
                                                                                                                                                                            
  Phenotype                   ER+ Her2--   6,159   1,737         28.2   \<0.0001                                   6,062         27.8       \<0.0001     761     45.1       \<0.0001
  ER+ Her2+                   609          219     36.0                                                 577        35.0                     107          53.0               
  ER--Her2+                   284          118     41.5                                                 260        38.8                     64           63.4               
  ER--Her2--                  862          201     23.3                                                 846        22.9                     106          54.6               
  ER+ Her2?                   1,426        381     26.7                                                 1,336      24.9                     242          72.7               
  ER--Her2?                   318          108     34.0                                                 299        32.4                     73           75.3               
                                                                                                                                                                            
  LVI                         No           8,037   2,241         27.9   \<0.0001                                   6,973         25.6       \<0.0001     844     47.3       \<0.0001
  Yes                         2,150        771     35.9                                                 2,146      35.9                     479          62.2               
  Unknown                     574          156     27.2                                                 481        27.2                     81           61.8               
                                                                                                                                                                            
  Grade                       1            2,969   715           24.1   \<0.0001   205           45.4   0.013      2,955         24.0       \<0.0001     310     43.8       \<0.0001
  2                           4,145        1,190   28.7                 420        40.0                 4,125      28.6                     626          53.1               
  3                           2,173        678     31.2                 401        44.6                 2,156      31.1                     384          57.2               
  No grade                    16           3       18.8                 117        29.1                 364        35.2                     84           65.6               
                                                                                                                                                                            
  Global tumor size, mm       \<20         5,032   833           16.6   \<0.0001   468           23.7   \<0.0001   4,566         15.8       \<0.0001     186     25.8       \<0.0001
  20--49.9                    4,072        1,298   31.9                 361        49.9                 3,711      30.1                     500          44.7               
  ≥50                         1,232        946     76.8                 200        82.0                 782        75.8                     677          86.6               
                                                                                                                                                                            
  Histology                   DCIS         1,161   481           41.4   \<0.0001                                                                                            
  Ductal                      7,278        1,926   26.5                                                 7,278      26.5          \<0.0001   948          49.2    \<0.0001   
  Lobular                     1,215        461     37.9                                                 1,215      37.9                     289          62.7               
  Others                      1,107        300     27.1                                                 1,107      27.1                     167          55.7               
                                                                                                                                                                            
  Periods                     1995--2004   3,407   1,117         32.8   \<0.0001   283           55.1   \<0.0001   3,124         30.8       \<0.0001     672     69.9       \<0.0001
  2005--2010                  2,511        788     31.4                 281        50.9                 2,230      28.9                     369          57.2               
  \>2010                      4,843        1,263   26.1                 597        30.5                 4,246      25.5                     363          33.6               
                                                                                                                                                                            
  Stage cT                    0            2,805   766           27.3   \<0.0001                                   2,529         26.3       \<0.0001     311     46.8       \<0.0001
  1                           4,003        999     25.0                                                 3,928      24.8                     464          47.6               
  2                           2,148        683     31.8                                                 2,114      31.8                     415          61.8               
  3                           174          83      47.7                                                 170        47.6                     69           85.2               
                                                                                                                                                                            
  Quadrant                    Central      589     235           39.9   \<0.0001   86            46.5   0.016      503           38.8       \<0.0001     110     56.4       \<0.0001
  Axillary                    198          57      28.8                 8          12.5                 190        29.5                     12           21.4               
  Others                                                                1,040      41.1                 8,743      27.1                     1,244        52.5               

**Note:**

Mastectomy rate for invasive BC among patients with reoperation.

**Abbreviations:** DCIS, ductal carcinoma in situ; BC, breast cancer; Her2?, Her2 unknown; IT, intratumoral; LVI, lymphovascular peritumoral invasion.

###### 

Factors associated with reoperation for DCIS BC: multivariate analysis

  Reoperation DCIS                *P*-value   OR      95% CI   
  ------------------ ------------ ----------- ------- -------- -------
                                                               
  Localization       Central                  1                
  Axillary           0.122        0.149       0.013   1.662    
  EIQ                0.052        0.481       0.230   1.008    
  IIQ                0.922        1.040       0.474   2.283    
  ESQ                0.036        0.531       0.295   0.958    
  ISQ                0.092        0.538       0.261   1.106    
  eEQ                0.572        1.233       0.596   2.554    
  eInfQ              0.911        0.951       0.393   2.299    
  eIntQ              0.740        1.150       0.505   2.620    
  eSupQ              0.056        0.489       0.235   1.018    
                                                               
  Age, years         ≤40                      1                
  41--50             0.961        0.984       0.522   1.856    
  51--74             0.010        0.464       0.259   0.831    
  ≥75                0.054        0.425       0.177   1.016    
                                                               
  Periods            1995--2004               1                0.920
  2005--2010         0.019        0.601       0.392   0.488    
  \>2010             \<0.0001     0.337       0.232            
                                                               
  Grade              1                        1                
  2                  0.347        0.813       0.529   1.251    
  3                  0.209        0.756       0.488   1.170    
  Unknown            0.028        0.499       0.268   0.929    
                                                               
  Size, mm           \<20                     1                
  20--49.9           \<0.0001     3.759       2.697   5.240    
  ≥50                \<0.0001     17.76       11.18   28.21    

**Abbreviations:** DCIS, ductal carcinoma in situ; BC, breast cancer; EIQ, external inferior quadrants; IIQ, internal inferior quadrant; ESQ, external superior quadrant; ISQ, internal superior quadrant; eEQ, equatorial external quadrant; eInfQ, equatorial inferior quadrant; eIntQ, equatorial internal quadrant; eSupQ, equatorial superior quadrant.

###### 

Factors associated with reoperation for invasive BC: multivariate analysis

  Reoperation invasive                            *P*-value   OR      95% CI   
  ----------------------- ----------------------- ----------- ------- -------- -------
                                                                               
  Localization            Central                             1                
  Axillary                0.020                   0.618       0.412   0.927    
  EIQ                     \<0.0001                0.582       0.445   0.762    
  IIQ                     \<0.0001                0.563       0.413   0.766    
  ESQ                     \<0.0001                0.527       0.422   0.659    
  ISQ                     \<0.0001                0.505       0.392   0.651    
  Inf M fold              0.001                   0.087       0.020   0.383    
  eEQ                     \<0.0001                0.624       0.480   0.813    
  eInfQ                   \<0.0001                0.431       0.310   0.601    
  eIntQ                   \<0.0001                0.494       0.352   0.693    
  eSupQ                   \<0.0001                0.531       0.412   0.684    
                                                                               
  Age, years              ≤40                                 1                
  41--50                  0.019                   0.786       0.642   0.961    
  51--74                  \<0.0001                0.558       0.463   0.672    
  ≥75                     \<0.0001                0.276       0.212   0.359    
                                                                               
  Periods                 1995--2004                          1                
  2005--2010              0.613                   0.041       0.891   1.217    
  \>2010                  0.863                   0.013       0.876   1.170    
  **NAC**                 NAC                                 0.651            
                                                                               
  **Histology**           Ductal                  0.006       1       0.478    0.886
  Lobular                 \<0.0001                0.960       1.678   2.290    
  Others                  0.819                   0.979       0.818   1.172    
                                                                               
  **Focality**            Unifocal                            1                
  Bifocal                 \<0.0001                2.911       2.398   3.534    
  Multifocal              \<0.0001                4.717       3.448   6.454    
  Unknown                 \<0.0001                3.481       2.214   5.472    
                                                                               
  **LVI**                 No                                  1                
  Yes                     0.004                   1.211       1.064   1.378    
                          Unknown                 0.025       1.383   1.042    1.836
  **DCIS componen**t      DCIS -- IT/peripheric   \<0.0001    2.490   2.237    2.772
                                                                               
  Grade                   1                                   1                
  2                       0.954                   0.004       0.884   1.140    
  3                       0.766                   1.026       0.867   1.213    
  Unknown                 0.474                   1.152       0.782   1.698    
                                                                               
  **Phenotype**           ER+ Her2--                                           
  ER+ Her2+               0.037                   1.252       1.014   1.545    
  ER-- Her2+              0.001                   1.692       1.235   2.317    
  ER-- Her2--             0.041                   0.802       0.649   0.991    
  ER+ Her2?               \<0.0001                0.608       0.504   0.733    
  ER-- Her2?              0.302                   0.848       0.619   1.160    
                                                                               
  **Size invasive, mm**   \<20                                1                
  20--49.9                \<0.0001                1.434       1.280   1.607    
  ≥50                     \<0.0001                9.324       7.389   11.766   

**Abbreviations:** BC, breast cancer; EIQ, external inferior quadrant; IIQ, internal inferior quadrant; ESQ, external superior quadrant; ISQ, internal superior quadrant; Inf M fold, inferior mammary fold; eEQ, equatorial external quadrant; eInfQ, equatorial inferior quadrant; eIntQ, equatorial internal quadrant; eSupQ, equatorial superior quadrant; NAC, neoadjuvant chemotherapy; LVI, lymphovascular peritumoral invasion; DCIS, ductal carcinoma in situ; IT, intratumoral.

###### 

Factors associated with reoperation with mastectomy for DCIS BC: multivariate analysis

  Mastectomy reoperation DCIS   *P*-value    OR      95% CI           
  ----------------------------- ------------ ------- -------- ------- --
                                                                      
  Localization                  Central              1                
  All others                    NS                                    
                                                                      
  Age, years                    ≤40                  1                
  41--50                        0.854        0.920   0.380    2.228   
                                                                      
  Periods                       1995--2004           1                
  2005--2010                    0.740        1.047   0.381    1.986   
  \>2010                        0.877        0.648   0.586    1.870   
  51--74                        0.129        0.870   0.369    1.135   
  ≥75                           0.939        0.947   0.230    3.896   
                                                                      
  Grade                         1                    1                
  2                             0.048        1.931   1.005    3.712   
  3                             0.980        1.008   0.527    1.928   
  Unknown                       0.202        1.966   0.695    5.557   
                                                                      
  Size, mm                      \<20                 1                
  20--49.9                      0.007        2.389   1.265    4.510   
  ≥50                           \<0.0001     18.02   9.189    35.34   

**Abbreviation:** DCIS, ductal carcinoma in situ; BC, breast cancer; NS, not significant.

###### 

Factors associated with reoperation with mastectomy for invasive BC: multivariate analysis

  Re-excision vs mastectomy Invasive   *P*-value                   OR      95% CI           
  ------------------------------------ --------------------------- ------- -------- ------- -------
                                                                                            
  Histology                            Ductal                              1                
  Lobular                              \<0.0001                    1.820   1.369    2.418   
  Others                               0.348                       1.175   0.839    1.646   
                                                                                            
  LVI                                  No                                  1                
  Yes                                  0.066                       1.247   0.985    1.578   
                                                                                            
  Periods                              1995--2004                          1                
  2005--2010                           0.552                       0.917   0.688    1.221   
  \>2010                               \<0.0001                    0.429   0.328    0.562   
                                                                                            
  Focality                             Unifocal                            1                
  Bifocal                              \<0.0001                    2.955   2.161    4.041   
  Multifocal                           \<0.0001                    9.334   5.497    15.85   
  Grade                                1                                   1                
                                                                                            
                                       2                           0.024   1.336    1.039   1.719
  3                                    0.039                       1.393   1.016    1.909   
  DCIS component                       DCIS -- IT and peripheric   0.393   0.911    0.736   1.128
                                                                                            
  Positive margins                     Focal                               1                
  Diffuse                              \<0.0001                    2.508   1.880    3.346   
                                                                                            
  Age, years                           ≤40                                 1                
  41--50                               0.835                       0.963   0.673    1.377   
  51--74                               0.002                       0.602   0.433    0.836   
  ≥75                                  0.309                       0.768   0.462    1.276   
                                                                                            
  Global size, mm                      \<20                                1                
  20--49.9                             \<0.0001                    2.372   1.856    3.032   
  ≥50                                  \<0.0001                    18.16   13.32    24.75   
                                                                                            
  Phenotype                            ER+ Her2--                          1                
  ER+ Her2+                            0.048                       1.453   1.003    2.105   
  ER-- Her2+                           0.007                       2.085   1.228    3.540   
  ER-- Her2--                          0.20                        1.294   0.873    1.919   

**Abbreviations:** BC, breast cancer; LVI, lymphovascular peritumoral invasion; DCIS, ductal carcinoma in situ; IT, intratumoral.

###### 

Factors associated with third operation with mastectomy: multivariate analysis

  Factors of mastectomy third operation Among re-excision   *P*-value                   OR         95% CI           
  --------------------------------------------------------- --------------------------- ---------- -------- ------- -------
                                                                                                                    
  Histology                                                 DCIS                                   1                
  Ductal                                                    0.937                       1.033      0.463    2.305   
  Lobular                                                   0.622                       1.244      0.523    2.960   
  Others                                                    0.903                       1.060      0.414    2.717   
  Global size, mm                                           \<20                                   1                
                                                                                                                    
                                                            20--49.9                    \<0.0001   2.374    1.463   3.852
  ≥50                                                       \<0.0001                    16.72      9.841    28.42   
                                                                                                                    
  Focality                                                  Unifocal                               1                
  Bifocal                                                   0.205                       1.471      0.809    2.675   
  Multifocal                                                0.017                       3.120      1.225    7.948   
                                                                                                                    
  LVI                                                       No                                     1                
  Yes                                                       0.532                       0.868      0.556    1.355   
  DCIS component                                            DCIS -- IT and peripheric   0.539      0.884    0.596   1.311
                                                                                                                    
  Phenotype                                                 ER+ Her2--                             1                
  ER+ Her2+                                                 0.175                       1.503      0.834    2.709   
  ER-- Her2+                                                0.524                       1.338      0.546    3.277   
  ER-- Her2--                                               0.787                       0.896      0.403    1.989   
                                                                                                                    
  Age, years                                                ≤40                                    1                
  41--50                                                    0.811                       1.073      0.601    1.916   
  51--74                                                    0.005                       0.448      0.256    0.784   
  ≥75                                                       0.033                       0.281      0.087    0.902   

**Abbreviations:** DCIS, ductal carcinoma in situ; LVI, lymphovascular peritumoral invasion; IT, intratumoral.
